A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirements
Christina Giannakou,1,2 Margriet VDZ Park,1 Wim H de Jong,1 Henk van Loveren,1,2 Rob J Vandebriel,1 Robert E Geertsma1 1Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, 2Department of Toxicogenomics, Maastricht University, Maastricht...
Main Authors: | Giannakou C, Park MV, de Jong WH, van Loveren H, Vandebriel RJ, Geertsma RE |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-06-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/a-comparison-of-immunotoxic-effects-of-nanomedicinal-products-with-reg-peer-reviewed-article-IJN |
Similar Items
-
Immunotoxicity Considerations for Next Generation Cancer Nanomedicines
by: Gary Hannon, et al.
Published: (2019-10-01) -
Nanomedicinal products: a survey on specific toxicity and side effects
by: Brand W, et al.
Published: (2017-08-01) -
Evaluating Immunotoxicity of Quaternary Ammonium Compounds
by: McDonald, Valerie Alexandra
Published: (2017) -
Zearalenone Mycotoxicosis: Pathophysiology and Immunotoxicity
by: Ajwad A. M. Assumaidaee, et al.
Published: (2020-06-01) -
The assessment of xenogeneic bone immunotoxicity and risk management study
by: Xiaoxia Sun, et al.
Published: (2019-11-01)